1
Home
Companies

Asarina Pharma

Asarina Pharma
Leadership team

Mr. Peter Nordkild (CEO & Chief Medical Officer)

Mr. Jakob Dynnes Hansen M.Sc., MBA (Chief Financial Officer)

Ms. Karin Ekberg (Chief Operating Officer)

Products/ Services
Biopharma, Biotechnology, Health Care, Pharmaceutical
Number of Employees
0 - 50
Headquarters
Solna, Stockholms Lan, Sweden
Established
2006
Traded as
NASDAQ:ASAP
Social Media
URL
https://www.asarinapharma.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Asarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and Tourette syndrome. The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016. Asarina Pharma AB (publ) was incorporated in 2005 and is based in Solna, Sweden.
History

Founded in 2010, Asarina Pharma is dedicated to the discovery, development and commercialization of innovative therapies for women's health disorders. The company develops non-hormonal treatments, offering relief at all stages of a woman’s life.

Mission
Our mission is to create treatments that improve the quality of life of women with conditions associated with the reproductive cycle, and to help reduce the burden of social, psychological, and economic suffering of these women.
Vision
Our vision is to become the leader in providing innovative and effective treatments that help improve the lives of women's health sufferers.
Key Team

Mr. Torbjörn Bäckström M.D., Ph.D. (Chief Science Officer & Chairman of Scientific Advisory Board)

Mr. Otto Skolling M.Sc (Chief Bus. Officer)

Mark DuBois (Communications Mang.)

Recognition and Awards
Asarina Pharma has received numerous awards, including 'Best Early-Stage Development Company' and 'Most Innovative European Biopharma' by Scrip Awards and 'Best New Drug' by the British Society of Sexual Medicine . Additionally, the company was a Finalist for 'Best European Start-up' at the European Business Awards.
References

https://in.investing.com/equities/asarina-pharma

https://finance.yahoo.com/quote/ASAP.ST/profile?p=ASAP.ST

https://www.crunchbase.com/organization/asarina-pharma

https://www.asarinapharma.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Asarina Pharma
Leadership team

Mr. Peter Nordkild (CEO & Chief Medical Officer)

Mr. Jakob Dynnes Hansen M.Sc., MBA (Chief Financial Officer)

Ms. Karin Ekberg (Chief Operating Officer)

Products/ Services
Biopharma, Biotechnology, Health Care, Pharmaceutical
Number of Employees
0 - 50
Headquarters
Solna, Stockholms Lan, Sweden
Established
2006
Traded as
NASDAQ:ASAP
Social Media
URL
https://www.asarinapharma.com